206 related articles for article (PubMed ID: 21436895)
1. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.
Nguyen le B; Diskin SJ; Capasso M; Wang K; Diamond MA; Glessner J; Kim C; Attiyeh EF; Mosse YP; Cole K; Iolascon A; Devoto M; Hakonarson H; Li HK; Maris JM
PLoS Genet; 2011 Mar; 7(3):e1002026. PubMed ID: 21436895
[TBL] [Abstract][Full Text] [Related]
2. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.
Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A
Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812
[TBL] [Abstract][Full Text] [Related]
3. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
[TBL] [Abstract][Full Text] [Related]
4. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.
Cimmino F; Avitabile M; Diskin SJ; Vaksman Z; Pignataro P; Formicola D; Cardinale A; Testori A; Koster J; de Torres C; Devoto M; Maris JM; Iolascon A; Capasso M
Int J Cancer; 2018 Dec; 143(11):2828-2837. PubMed ID: 30132831
[TBL] [Abstract][Full Text] [Related]
5. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM
Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027
[TBL] [Abstract][Full Text] [Related]
6. The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population.
Zhang R; Zou Y; Zhu J; Zeng X; Yang T; Wang F; He J; Xia H
Int J Med Sci; 2016; 13(2):133-8. PubMed ID: 26941572
[TBL] [Abstract][Full Text] [Related]
7. Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of LMO1.
Lu J; Chu P; Wang H; Jin Y; Han S; Han W; Tai J; Guo Y; Ni X
PLoS One; 2015; 10(6):e0127856. PubMed ID: 26030754
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variants in NEFL influence gene expression and neuroblastoma risk.
Capasso M; Diskin S; Cimmino F; Acierno G; Totaro F; Petrosino G; Pezone L; Diamond M; McDaniel L; Hakonarson H; Iolascon A; Devoto M; Maris JM
Cancer Res; 2014 Dec; 74(23):6913-24. PubMed ID: 25312269
[TBL] [Abstract][Full Text] [Related]
9. Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans.
Latorre V; Diskin SJ; Diamond MA; Zhang H; Hakonarson H; Maris JM; Devoto M
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):658-63. PubMed ID: 22328350
[TBL] [Abstract][Full Text] [Related]
10. LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population.
He J; Zhong W; Zeng J; Zhu J; Zhang R; Wang F; Yang T; Zou Y; Xia H
Oncotarget; 2016 Apr; 7(16):22770-8. PubMed ID: 27009839
[TBL] [Abstract][Full Text] [Related]
11. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
Capasso M; Devoto M; Hou C; Asgharzadeh S; Glessner JT; Attiyeh EF; Mosse YP; Kim C; Diskin SJ; Cole KA; Bosse K; Diamond M; Laudenslager M; Winter C; Bradfield JP; Scott RH; Jagannathan J; Garris M; McConville C; London WB; Seeger RC; Grant SF; Li H; Rahman N; Rappaport E; Hakonarson H; Maris JM
Nat Genet; 2009 Jun; 41(6):718-23. PubMed ID: 19412175
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.
Maris JM; Mosse YP; Bradfield JP; Hou C; Monni S; Scott RH; Asgharzadeh S; Attiyeh EF; Diskin SJ; Laudenslager M; Winter C; Cole KA; Glessner JT; Kim C; Frackelton EC; Casalunovo T; Eckert AW; Capasso M; Rappaport EF; McConville C; London WB; Seeger RC; Rahman N; Devoto M; Grant SF; Li H; Hakonarson H
N Engl J Med; 2008 Jun; 358(24):2585-93. PubMed ID: 18463370
[TBL] [Abstract][Full Text] [Related]
13. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.
Bosse KR; Diskin SJ; Cole KA; Wood AC; Schnepp RW; Norris G; Nguyen le B; Jagannathan J; Laquaglia M; Winter C; Diamond M; Hou C; Attiyeh EF; Mosse YP; Pineros V; Dizin E; Zhang Y; Asgharzadeh S; Seeger RC; Capasso M; Pawel BR; Devoto M; Hakonarson H; Rappaport EF; Irminger-Finger I; Maris JM
Cancer Res; 2012 Apr; 72(8):2068-78. PubMed ID: 22350409
[TBL] [Abstract][Full Text] [Related]
14.
Zhang Z; Zou Y; Zhu J; Zhang R; Yang T; Wang F; Xia H; He J; Feng Z
Onco Targets Ther; 2017; 10():1969-1975. PubMed ID: 28435286
[TBL] [Abstract][Full Text] [Related]
15. Genetic Analysis in African American Children Supports Ancestry-Specific Neuroblastoma Susceptibility.
Testori A; Vaksman Z; Diskin SJ; Hakonarson H; Capasso M; Iolascon A; Maris JM; Devoto M
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):870-875. PubMed ID: 35131881
[TBL] [Abstract][Full Text] [Related]
16. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
[TBL] [Abstract][Full Text] [Related]
17. Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
Pinto N; Gamazon ER; Antao N; Myers J; Stark AL; Konkashbaev A; Im HK; Diskin SJ; London WB; Ludeman SM; Maris JM; Cox NJ; Cohn SL; Dolan ME
Clin Pharmacol Ther; 2014 Jun; 95(6):644-52. PubMed ID: 24549002
[TBL] [Abstract][Full Text] [Related]
18. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ
J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701
[TBL] [Abstract][Full Text] [Related]
19. Genetic susceptibility to neuroblastoma.
Tolbert VP; Coggins GE; Maris JM
Curr Opin Genet Dev; 2017 Feb; 42():81-90. PubMed ID: 28458126
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation associated with childhood and adult stature and risk of MYCN-amplified neuroblastoma.
Semmes EC; Shen E; Cohen JL; Zhang C; Wei Q; Hurst JH; Walsh KM
Cancer Med; 2020 Nov; 9(21):8216-8225. PubMed ID: 32945147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]